측방유동 어세이 시장 : 지역별(북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카) : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2031년)

Persistence Market Research unveils a comprehensive analysis of the global lateral flow assay market, providing deep insights into its growth trajectory, challenges, and emerging trends. This detailed report offers exclusive data and statistics forecasting the market's progression from 2024 to 2031.

Key Insights:

• Lateral Flow Assay Market Size (2024E): US$ 9.1 Billion
• Projected Market Value (2031F): US$ 12.4 Billion
• Global Market Growth Rate (CAGR 2024 to 2031): 4.50%

Lateral Flow Assay Market - Report Scope:

Lateral flow assay, a rapid diagnostic method, plays a pivotal role in various industries, including healthcare, food safety, veterinary diagnostics, and environmental testing. Utilizing its simplicity, speed, and cost-effectiveness, lateral flow assays find extensive application in point-of-care testing, home diagnostics, and on-site screening.

The global lateral flow assay market experiences substantial growth driven by factors such as the increasing prevalence of infectious diseases, the rising demand for rapid diagnostic solutions, and advancements in assay technologies. Moreover, the expanding applications of lateral flow assays beyond healthcare, such as in food safety and environmental monitoring, further propel market growth.

Market Growth Drivers:

The escalating incidence of infectious diseases worldwide, coupled with the need for rapid and accurate diagnostic solutions, drives the demand for lateral flow assays in the healthcare sector. With the emergence of novel pathogens and the persistence of endemic diseases, there is a growing emphasis on early detection and prompt intervention, fueling the adoption of lateral flow assays.Furthermore, technological advancements in lateral flow assay platforms enhance their sensitivity, specificity, and multiplexing capabilities, widening their utility across diverse applications. Additionally, the increasing awareness regarding the importance of food safety and environmental monitoring drives the demand for lateral flow assays in these sectors, contributing to market growth.

Market Restraints:

Despite the significant growth prospects, the global lateral flow assay market faces challenges such as the limited sensitivity and specificity of conventional assays, leading to false-positive or false-negative results. Addressing these limitations requires continuous innovation and optimization of assay components, which may pose technical and regulatory hurdles.

Moreover, the competitive landscape of the lateral flow assay market is characterized by the presence of numerous players offering similar products, intensifying price competition and margin pressures. Additionally, stringent regulatory requirements for product validation and approval add complexity to market entry, particularly for new entrants and small-scale manufacturers.

Market Opportunities:

The ongoing advancements in assay technologies, including the integration of microfluidics, digital imaging, and smartphone-based detection, present lucrative opportunities for innovation and market expansion in the lateral flow assay segment. These developments enable enhanced sensitivity, quantitative analysis, and connectivity, catering to the evolving needs of end-users across various industries.Furthermore, the increasing adoption of lateral flow assays in emerging economies, driven by rising healthcare expenditure, improving healthcare infrastructure, and growing awareness about infectious diseases, offers significant growth potential. Additionally, partnerships and collaborations between diagnostic companies, research institutions, and government agencies facilitate technology transfer, capacity building, and market access in untapped regions.

Key Questions Answered in the Report:

• Which segments and applications are driving the growth of the lateral flow assay market?
• What are the key technological advancements and innovations shaping the future of lateral flow assays?
• How do regulatory frameworks and reimbursement policies influence market dynamics and competition?
• Who are the leading players and what are their strategies to maintain market dominance and competitiveness?
• What are the emerging trends and future prospects in the global lateral flow assay market?

Competitive Intelligence and Business Strategy:

To stay ahead in the competitive landscape, key players in the lateral flow assay market focus on product innovation, strategic partnerships, and geographic expansion. Companies such as Abbott Laboratories, F. Hoffmann-La Roche Ltd, and Danaher Corporation invest in research and development to launch next-generation lateral flow assay platforms with improved performance and usability. Moreover, strategic collaborations with healthcare providers, distribution partners, and regulatory agencies enable companies to penetrate new markets, enhance customer reach, and navigate regulatory challenges effectively. In summary, a combination of innovation, collaboration, and market diversification strategies ensures sustained growth and competitiveness in the dynamic lateral flow assay market.

Key Companies Profiled:

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• Siemens Healthineers AG
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• QIAGEN N.V.
• Merck KGaA
• PerkinElmer, Inc.

Lateral Flow Assay Market Research Segmentation:

Lateral Flow Assay Market by Product Type:

• LFA Readers
• Benchtop Readers
• Handheld Readers
• LFA Kits
• Test Strips
• Dipsticks
• Cassettes
• Lancets

Lateral Flow Assay Market by Application:

• Sexually Transmitted Diseases
• Human Deficiency Virus (HIV) Infection
• Gonorrhoea
• Syphilis
• Others
• Infectious Diseases
• Mosquito-Borne Diseases
• Streptococcus Infections
• Hepatitis Infection
• Gastrointestinal Infections
• Respiratory Tract Infections
• Others
• Diabetes
• Pregnancy and Fertility Testing
• Drug of Abuse Testing

Lateral Flow Assay Market by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Supermarkets/Hypermarkets
• e-Commerce

Lateral Flow Assay Market by Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Technology Roadmap
• 1.5. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption / Usage Analysis
• 4.2. Product USPs / Features
• 4.3. Key Promotional Strategies
• 4.4. Regulatory Scenario
• 4.5. PESTLE Analysis
• 4.6. Porter's Analysis
• 4.7. Regional Epidemiology
• 4.8. Recent Product Launches and Approvals

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Increasing Spending on Healthcare Per Capita
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Top Companies Historical Growth
  • 5.2.2. Growing Usage of Home-based Lateral Flow Assay Devices
  • 5.2.3. Increasing Global Prevalence of Acute and Chronic Infectious Diseases
  • 5.2.4. Rising Geriatric Population
  • 5.2.5. Entry of Domestic Players into the Market
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. Global Lateral Flow Assay Market- COVID-19 Crisis - Impact Assessment

• 6.1. Current Statistics and Probable Future Impact
• 6.2. Impact of COVID-19
• 6.3. Impact Analysis, By segment

7. Global Lateral Flow Assay Market - Pricing Analysis

• 7.1. Regional Pricing Analysis By Product Type
• 7.2. Global Average Pricing Analysis Benchmark

8. Global Lateral Flow Assay Market Volume (in 000 Units) Analysis 2012-2023 and Forecast, 2024-2031

• 8.1. Historical Market Volume (in 000 Units) Analysis, 2012-2023
• 8.2. Current and Future Market Volume (in 000 Units) Projections, 2024-2031
  • 8.2.1. Y-o-Y Growth Trend Analysis

9. Global Lateral Flow Assay Market (in Value or Size in US$ Mn) Analysis 2012-2023 and Forecast, 2024-2031

• 9.1. Historical Market Value (US$ Mn) Analysis, 2012-2023
• 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031, by Product Type

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2012-2023
• 10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2024-2031
  • 10.3.1. Readers
    • 10.3.1.1. Bench-Top Readers
    • 10.3.1.2. Hand-held Readers
  • 10.3.2. LFA Kits
    • 10.3.2.1. Test Strips
    • 10.3.2.2. Dipsticks
    • 10.3.2.3. Cassettes
    • 10.3.2.4. Lancets
• 10.4. Market Attractiveness Analysis By Product Type

11. Global Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031, by Application

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis By Application, 2012-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2031
  • 11.3.1. Sexually Transmitted Diseases
    • 11.3.1.1. Human Deficiency Virus (HIV) Infection
    • 11.3.1.2. Gonorrhoea
    • 11.3.1.3. Syphilis
    • 11.3.1.4. Others
  • 11.3.2. Infectious Diseases
    • 11.3.2.1. Mosquito-Borne Diseases
    • 11.3.2.2. Streptococcus Infections
    • 11.3.2.3. Hepatitis Infection
    • 11.3.2.4. Gastrointestinal Infections
    • 11.3.2.5. Respiratory Tract Infections
    • 11.3.2.6. Others
  • 11.3.3. Diabetes
  • 11.3.4. Pregnancy and Fertility Testing
  • 11.3.5. Drug of Abuse Testing
• 11.4. Market Attractiveness Analysis By Application

12. Global Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031, by Distribution Channel

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Mn) Analysis By Application, 2012-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2031
  • 12.3.1. Hospital Pharmacies
  • 12.3.2. Retail Pharmacies
  • 12.3.3. Supermarket/Hypermarket
  • 12.3.4. E-Commerce
• 12.4. Market Attractiveness Analysis By Application

13. Global Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031, by Region

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2023
• 13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2031
  • 13.3.1. North America
  • 13.3.2. Latin America
  • 13.3.3. Europe
  • 13.3.4. South Asia
  • 13.3.5. East Asia
  • 13.3.6. Oceania
  • 13.3.7. Middle East and Africa (MEA)
• 13.4. Market Attractiveness Analysis By Region

14. North America Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
• 14.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
  • 14.3.1. By Country
    • 14.3.1.1. U.S.
    • 14.3.1.2. Canada
  • 14.3.2. By Product Type
  • 14.3.3. By Application
  • 14.3.4. By Distribution Channel
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product Type
  • 14.4.3. By Application
  • 14.4.4. By Distribution Channel
• 14.5. Country Level Analysis & Forecast
  • 14.5.1. U.S. Lateral Flow Assay Analysis
    • 14.5.1.1. Introduction
    • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.1.2.1. By Product Type
      • 14.5.1.2.2. By Application
      • 14.5.1.2.3. By Distribution Channel
  • 14.5.2. Canada Lateral Flow Assay Analysis
    • 14.5.2.1. Introduction
    • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.2.2.1. By Product Type
      • 14.5.2.2.2. By Application
      • 14.5.2.2.3. By Distribution Channel
• 14.6. Key Market Participants - Intensity Mapping
• 14.7. Drivers and Restraints - Impact Analysis

15. Latin America Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
• 15.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
  • 15.3.1. By Country
    • 15.3.1.1. Brazil
    • 15.3.1.2. Mexico
    • 15.3.1.3. Argentina
    • 15.3.1.4. Rest of Latin America
  • 15.3.2. By Product Type
  • 15.3.3. By Application
  • 15.3.4. By Distribution Channel
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product Type
  • 15.4.3. By Application
  • 15.4.4. By Distribution Channel
• 15.5. Country Level Analysis & Forecast
  • 15.5.1. Brazil Lateral Flow Assay Analysis
    • 15.5.1.1. .Introduction
    • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.1.2.1. By Product Type
      • 15.5.1.2.2. By Application
      • 15.5.1.2.3. By Distribution Channel
  • 15.5.2. Mexico Lateral Flow Assay Analysis
    • 15.5.2.1. Introduction
    • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.2.2.1. By Product Type
      • 15.5.2.2.2. By Application
      • 15.5.2.2.3. By Distribution Channel
  • 15.5.3. Argentina Lateral Flow Assay Analysis
    • 15.5.3.1. Introduction
    • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.3.2.1. By Product Type
      • 15.5.3.2.2. By Application
      • 15.5.3.2.3. By Distribution Channel
• 15.6. Key Market Participants - Intensity Mapping
• 15.7. Drivers and Restraints - Impact Analysis

16. Europe Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
• 16.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
  • 16.3.1. By Country
    • 16.3.1.1. Germany
    • 16.3.1.2. France
    • 16.3.1.3. Italy
    • 16.3.1.4. U.K.
    • 16.3.1.5. Spain
    • 16.3.1.6. Russia
    • 16.3.1.7. Nordic Countries
    • 16.3.1.8. BENELUX
    • 16.3.1.9. Rest of Europe
  • 16.3.2. By Product Type
  • 16.3.3. By Application
  • 16.3.4. By Distribution Channel
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product Type
  • 16.4.3. By Application
  • 16.4.4. By Distribution Channel
• 16.5. Country Level Analysis & Forecast
  • 16.5.1. Germany Lateral Flow Assay Analysis
    • 16.5.1.1. .Introduction
    • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.1.2.1. By Product Type
      • 16.5.1.2.2. By Application
      • 16.5.1.2.3. By Distribution Channel
  • 16.5.2. France Lateral Flow Assay Analysis
    • 16.5.2.1. Introduction
    • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.2.2.1. By Product Type
      • 16.5.2.2.2. By Application
      • 16.5.2.2.3. By Distribution Channel
  • 16.5.3. Italy Lateral Flow Assay Analysis
    • 16.5.3.1. Introduction
    • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.3.2.1. By Product Type
      • 16.5.3.2.2. By Application
      • 16.5.3.2.3. By Distribution Channel
  • 16.5.4. U.K. Lateral Flow Assay Analysis
    • 16.5.4.1. .Introduction
    • 16.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.4.2.1. By Product Type
      • 16.5.4.2.2. By Application
      • 16.5.4.2.3. By Distribution Channel
  • 16.5.5. Spain Lateral Flow Assay Analysis
    • 16.5.5.1. .Introduction
    • 16.5.5.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.5.2.1. By Product Type
      • 16.5.5.2.2. By Application
      • 16.5.5.2.3. By Distribution Channel
  • 16.5.6. Russia Lateral Flow Assay Analysis
    • 16.5.6.1. .Introduction
    • 16.5.6.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.6.2.1. By Product Type
      • 16.5.6.2.2. By Application
      • 16.5.6.2.3. By Distribution Channel
  • 16.5.7. Nordic Countries Lateral Flow Assay Analysis
    • 16.5.7.1. .Introduction
    • 16.5.7.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.7.2.1. By Product Type
      • 16.5.7.2.2. By Application
      • 16.5.7.2.3. By Distribution Channel
  • 16.5.8. BENELUX Lateral Flow Assay Analysis
    • 16.5.8.1. .Introduction
    • 16.5.8.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.8.2.1. By Product Type
      • 16.5.8.2.2. By Application
      • 16.5.8.2.3. By Distribution Channel
• 16.6. Key Market Participants - Intensity Mapping
• 16.7. Drivers and Restraints - Impact Analysis

17. South Asia Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
• 17.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
  • 17.3.1. By Country
    • 17.3.1.1. India
    • 17.3.1.2. Indonesia
    • 17.3.1.3. Malaysia
    • 17.3.1.4. Philippines
    • 17.3.1.5. Thailand
    • 17.3.1.6. Vietnam
    • 17.3.1.7. Rest of South Asia
  • 17.3.2. By Product Type
  • 17.3.3. By Application
  • 17.3.4. By Distribution Channel
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product Type
  • 17.4.3. By Application
  • 17.4.4. By Distribution Channel
• 17.5. Country Level Analysis & Forecast
  • 17.5.1. India Lateral Flow Assay Analysis
    • 17.5.1.1. .Introduction
    • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.1.2.1. By Product Type
      • 17.5.1.2.2. By Application
      • 17.5.1.2.3. By Distribution Channel
  • 17.5.2. Indonesia Lateral Flow Assay Analysis
    • 17.5.2.1. Introduction
    • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.2.2.1. By Product Type
      • 17.5.2.2.2. By Application
      • 17.5.2.2.3. By Distribution Channel
  • 17.5.3. Malaysia Lateral Flow Assay Analysis
    • 17.5.3.1. Introduction
    • 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.3.2.1. By Product Type
      • 17.5.3.2.2. By Application
      • 17.5.3.2.3. By Distribution Channel
  • 17.5.4. Philippines Lateral Flow Assay Analysis
    • 17.5.4.1. .Introduction
    • 17.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.4.2.1. By Product Type
      • 17.5.4.2.2. By Application
      • 17.5.4.2.3. By Distribution Channel
  • 17.5.5. Thailand Lateral Flow Assay Analysis
    • 17.5.5.1. .Introduction
    • 17.5.5.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.5.2.1. By Product Type
      • 17.5.5.2.2. By Application
      • 17.5.5.2.3. By Distribution Channel
  • 17.5.6. Vietnam Lateral Flow Assay Analysis
    • 17.5.6.1. .Introduction
    • 17.5.6.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.6.2.1. By Product Type
      • 17.5.6.2.2. By Application
      • 17.5.6.2.3. By Distribution Channel
• 17.6. Key Market Participants - Intensity Mapping
• 17.7. Drivers and Restraints - Impact Analysis

18. East Asia Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
• 18.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
  • 18.3.1. By Country
    • 18.3.1.1. China
    • 18.3.1.2. Japan
    • 18.3.1.3. South Korea
  • 18.3.2. By Product Type
  • 18.3.3. By Application
  • 18.3.4. By Distribution Channel
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product Type
  • 18.4.3. By Application
  • 18.4.4. By Distribution Channel
• 18.5. Country Level Analysis & Forecast
  • 18.5.1. China Lateral Flow Assay Analysis
    • 18.5.1.1. .Introduction
    • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.1.2.1. By Product Type
      • 18.5.1.2.2. By Application
      • 18.5.1.2.3. By Distribution Channel
  • 18.5.2. Japan Lateral Flow Assay Analysis
    • 18.5.2.1. Introduction
    • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.2.2.1. By Product Type
      • 18.5.2.2.2. By Application
      • 18.5.2.2.3. By Distribution Channel
  • 18.5.3. South Korea Lateral Flow Assay Analysis
    • 18.5.3.1. Introduction
    • 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.3.2.1. By Product Type
      • 18.5.3.2.2. By Application
      • 18.5.3.2.3. By Distribution Channel
• 18.6. Key Market Participants - Intensity Mapping
• 18.7. Drivers and Restraints - Impact Analysis

19. Oceania Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
• 19.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
  • 19.3.1. By Country
    • 19.3.1.1. Australia
    • 19.3.1.2. New Zealand
  • 19.3.2. By Product Type
  • 19.3.3. By Application
  • 19.3.4. By Distribution Channel
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product Type
  • 19.4.3. By Application
  • 19.4.4. By Distribution Channel
• 19.5. Country Level Analysis & Forecast
  • 19.5.1. Australia Lateral Flow Assay Analysis
    • 19.5.1.1. .Introduction
    • 19.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.1.2.1. By Product Type
      • 19.5.1.2.2. By Application
      • 19.5.1.2.3. By Distribution Channel
  • 19.5.2. New Zealand Lateral Flow Assay Analysis
    • 19.5.2.1. Introduction
    • 19.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.2.2.1. By Product Type
      • 19.5.2.2.2. By Application
      • 19.5.2.2.3. By Distribution Channel
• 19.6. Key Market Participants - Intensity Mapping
• 19.7. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
• 20.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
  • 20.3.1. By Country
    • 20.3.1.1. Turkey
    • 20.3.1.2. GCC Countries
    • 20.3.1.3. Northern Africa
    • 20.3.1.4. South Africa
    • 20.3.1.5. Rest of Middle East and Africa
  • 20.3.2. By Product Type
  • 20.3.3. By Application
  • 20.3.4. By Distribution Channel
• 20.4. Market Attractiveness Analysis
  • 20.4.1. By Country
  • 20.4.2. By Product Type
  • 20.4.3. By Application
  • 20.4.4. By Distribution Channel
• 20.5. Country Level Analysis & Forecast
  • 20.5.1. Turkey Lateral Flow Assay Analysis
    • 20.5.1.1. Introduction
    • 20.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 20.5.1.2.1. By Product Type
      • 20.5.1.2.2. By Application
      • 20.5.1.2.3. By Distribution Channel
  • 20.5.2. GCC Countries Lateral Flow Assay Analysis
    • 20.5.2.1. Introduction
    • 20.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 20.5.2.2.1. By Product Type
      • 20.5.2.2.2. By Application
      • 20.5.2.2.3. By Distribution Channel
  • 20.5.3. Northern Africa Lateral Flow Assay Analysis
    • 20.5.3.1. Introduction
    • 20.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 20.5.3.2.1. By Product Type
      • 20.5.3.2.2. By Application
      • 20.5.3.2.3. By Distribution Channel
  • 20.5.4. South Africa Lateral Flow Assay Analysis
    • 20.5.4.1. Introduction
    • 20.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 20.5.4.2.1. By Product Type
      • 20.5.4.2.2. By Application
      • 20.5.4.2.3. By Distribution Channel
• 20.6. Key Market Participants - Intensity Mapping
• 20.7. Drivers and Restraints - Impact Analysis

21. Market Structure Analysis

• 21.1. Market Analysis by Tier of Companies (Lateral Flow Assay)
• 21.2. Market Share Analysis of Top Players

22. Competition Analysis

• 22.1. Competition Dashboard
• 22.2. Competition Benchmarking
• 22.3. Competition Deep Dive
  • 22.3.1. Thermo Fisher Scientific Inc.
    • 22.3.1.1. Overview
    • 22.3.1.2. Product Portfolio
    • 22.3.1.3. Sales Footprint
    • 22.3.1.4. Strategy Overview
    • 22.3.1.5. Key Financials
    • 22.3.1.6. SWOT analysis
  • 22.3.2. F. Hoffmann-La Roche
    • 22.3.2.1. Overview
    • 22.3.2.2. Product Portfolio
    • 22.3.2.3. Sales Footprint
    • 22.3.2.4. Strategy Overview
    • 22.3.2.5. Key Financials
    • 22.3.2.6. SWOT analysis
  • 22.3.3. Abbott Laboratories
    • 22.3.3.1. Overview
    • 22.3.3.2. Product Portfolio
    • 22.3.3.3. Sales Footprint
    • 22.3.3.4. Strategy Overview
    • 22.3.3.5. Key Financials
    • 22.3.3.6. SWOT analysis
  • 22.3.4. Becton, Dickinson & Company
    • 22.3.4.1. Overview
    • 22.3.4.2. Product Portfolio
    • 22.3.4.3. Sales Footprint
    • 22.3.4.4. Strategy Overview
    • 22.3.4.5. Key Financials
    • 22.3.4.6. SWOT analysis
  • 22.3.5. PerkinElmer Inc.
    • 22.3.5.1. Overview
    • 22.3.5.2. Product Portfolio
    • 22.3.5.3. Sales Footprint
    • 22.3.5.4. Strategy Overview
    • 22.3.5.5. Key Financials
    • 22.3.5.6. SWOT analysis
  • 22.3.6. Siemens Healthineers
    • 22.3.6.1. Overview
    • 22.3.6.2. Product Portfolio
    • 22.3.6.3. Sales Footprint
    • 22.3.6.4. Strategy Overview
    • 22.3.6.5. Key Financials
    • 22.3.6.6. SWOT analysis
  • 22.3.7. QIAGEN N.V.
    • 22.3.7.1. Overview
    • 22.3.7.2. Product Portfolio
    • 22.3.7.3. Sales Footprint
    • 22.3.7.4. Strategy Overview
    • 22.3.7.5. Key Financials
    • 22.3.7.6. SWOT analysis
  • 22.3.8. bioMerieux SA
    • 22.3.8.1. Overview
    • 22.3.8.2. Product Portfolio
    • 22.3.8.3. Sales Footprint
    • 22.3.8.4. Strategy Overview
    • 22.3.8.5. Key Financials
    • 22.3.8.6. SWOT analysis
  • 22.3.9. Bio-Rad Laboratories, Inc.
    • 22.3.9.1. Overview
    • 22.3.9.2. Product Portfolio
    • 22.3.9.3. Sales Footprint
    • 22.3.9.4. Strategy Overview
    • 22.3.9.5. Key Financials
    • 22.3.9.6. SWOT analysis
  • 22.3.10. Maternova Inc.
    • 22.3.10.1. Overview
    • 22.3.10.2. Product Portfolio
    • 22.3.10.3. Sales Footprint
    • 22.3.10.4. Strategy Overview
    • 22.3.10.5. Key Financials
    • 22.3.10.6. SWOT analysis
  • 22.3.11. Quidel Corporation
    • 22.3.11.1. Overview
    • 22.3.11.2. Product Portfolio
    • 22.3.11.3. Sales Footprint
    • 22.3.11.4. Strategy Overview
    • 22.3.11.5. Key Financials
    • 22.3.11.6. SWOT analysis
  • 22.3.12. Healgen Scientific, LLC.
    • 22.3.12.1. Overview
    • 22.3.12.2. Product Portfolio
    • 22.3.12.3. Sales Footprint
    • 22.3.12.4. Strategy Overview
    • 22.3.12.5. Key Financials
    • 22.3.12.6. SWOT analysis
  • 22.3.13. Meridian Bioscience Inc.
    • 22.3.13.1. Overview
    • 22.3.13.2. Product Portfolio
    • 22.3.13.3. Sales Footprint
    • 22.3.13.4. Strategy Overview
    • 22.3.13.5. Key Financials
    • 22.3.13.6. SWOT analysis
  • 22.3.14. Abcam plc.
    • 22.3.14.1. Overview
    • 22.3.14.2. Product Portfolio
    • 22.3.14.3. Sales Footprint
    • 22.3.14.4. Strategy Overview
    • 22.3.14.5. Key Financials
    • 22.3.14.6. SWOT analysis
  • 22.3.15. Access Bio, Inc.
    • 22.3.15.1. Overview
    • 22.3.15.2. Product Portfolio
    • 22.3.15.3. Sales Footprint
    • 22.3.15.4. Strategy Overview
    • 22.3.15.5. Key Financials
    • 22.3.15.6. SWOT analysis
  • 22.3.16. Humasis Co. Ltd.
    • 22.3.16.1. Overview
    • 22.3.16.2. Product Portfolio
    • 22.3.16.3. Sales Footprint
    • 22.3.16.4. Strategy Overview
    • 22.3.16.5. Key Financials
    • 22.3.16.6. SWOT analysis
  • 22.3.17. DIALUNOX GmbH
    • 22.3.17.1. Overview
    • 22.3.17.2. Product Portfolio
    • 22.3.17.3. Sales Footprint
    • 22.3.17.4. Strategy Overview
    • 22.3.17.5. Key Financials
    • 22.3.17.6. SWOT analysis
  • 22.3.18. Detekt Biomedical LLC
    • 22.3.18.1. Overview
    • 22.3.18.2. Product Portfolio
    • 22.3.18.3. Sales Footprint
    • 22.3.18.4. Strategy Overview
    • 22.3.18.5. Key Financials
    • 22.3.18.6. SWOT analysis
  • 22.3.19. Guangzhou Wondfo Biotech Co., Ltd.
    • 22.3.19.1. Overview
    • 22.3.19.2. Product Portfolio
    • 22.3.19.3. Sales Footprint
    • 22.3.19.4. Strategy Overview
    • 22.3.19.5. Key Financials
    • 22.3.19.6. SWOT analysis
  • 22.3.20. Creative Diagnostics
    • 22.3.20.1. Overview
    • 22.3.20.2. Product Portfolio
    • 22.3.20.3. Sales Footprint
    • 22.3.20.4. Strategy Overview
    • 22.3.20.5. Key Financials
    • 22.3.20.6. SWOT analysis

23. Assumptions and Acronyms Used

24. Research Methodology